Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
BEFREE |
The EBER (+)/TP53 (+) component with massive lymphoid infiltrate surrounded the EBER (-)/TP53 (-) component showing well to moderately differentiated tubular adenocarcinoma.
|
26617924 |
2015 |
Adenocarcinoma, Tubular
|
0.540 |
GeneticVariation
|
disease |
BEFREE |
We demonstrated that the dormant and aggressive variants of tubular adenocarcinomas (TUBs) of the stomach are characterized by loss of MYC and gain of TP53 and gain of MYC and/or loss of TP53, respectively.
|
23866769 |
2013 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
CTD_human |
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
|
22484628 |
2012 |
Adenocarcinoma, Tubular
|
0.540 |
Therapeutic
|
disease |
CTD_human |
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
|
22484628 |
2012 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
BEFREE |
However, array CGH revealed that, of the 13 intramucosal TUBs examined, loss of MYC (MYC-) and gain of TP53 (TP53+) was detected in 9 TUBs and MYC+ and/or TP53- was detected in 3 TUBs.
|
20565940 |
2010 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
CTD_mouse |
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
|
16247444 |
2006 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
BEFREE |
The inactivation of wild-type TP53 is an earlier event before dedifferentiation of TUB to mixed-type UGC, but is less frequent and a later event in a subset of mixed-type UGC deriving from SIG..
|
16785766 |
2006 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
CTD_human |
[Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
|
11798837 |
2000 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
CTD_human |
Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure.
|
10797276 |
2000 |
Adenocarcinoma, Tubular
|
0.540 |
Therapeutic
|
disease |
CTD_human |
[Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
|
11798837 |
2000 |
Adenocarcinoma, Tubular
|
0.540 |
Therapeutic
|
disease |
CTD_human |
Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure.
|
10797276 |
2000 |
Adenocarcinoma, Tubular
|
0.540 |
Biomarker
|
disease |
CTD_mouse |
Endometrial carcinogenesis induced by concurrent oral administration of ethylenethiourea and sodium nitrite in mice.
|
7955072 |
1994 |